MAPK8 and uterine carcinoma: Moreover, Jun N-terminal kinase inhibitor (JNK-I) was found to inhibit the proliferation of human uterine carcinoma FU-MMT-1 cells and block FU-MMT-1-stimulated human arterial endothelial cell (HAEC) tube formation, suggesting that JNK-I is an anti-angiogenic agent [43].